Regulation of normal and leukemic hematopoiesis by type I interferon
I 型干扰素对正常和白血病造血的调节
基本信息
- 批准号:8127112
- 负责人:
- 金额:$ 5.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-05-01 至 2012-04-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAffectAntiviral AgentsApoptosisAutoimmune DiseasesBiologyBlood CellsBone Marrow CellsCellsCellular biologyChronicChronic Myeloid LeukemiaClinicClinicalCuesDataDevelopmentEquilibriumExposure toFamilyGoalsHealthHematologic NeoplasmsHematological DiseaseHematopoiesisHematopoieticHematopoietic stem cellsHomeostasisHumanImatinibIn VitroInfectionInflammatoryInterferon Type IInterferonsKnowledgeLeadLeukemic Hematopoietic Stem CellMediatingModalityMolecularMyelogenousMyeloid Progenitor CellsMyeloproliferative diseasePlayPoly I-CPopulationPopulation DecreasesPredispositionProcessProliferatingPropertyProteinsPublic HealthRegulationRoche brand of peginterferon alfa-2aRoleSignal PathwaySignal TransductionSorting - Cell MovementStem cellsStressTherapeutic InterventionToxic effectTransgenic MiceTyrosine Kinase InhibitorWild Type MouseWorkbasebcr-abl Fusion Proteinscell typechemotherapeutic agentcombinatorialcytokinedesignhematopoietic stem cell fatein vivointerestkinase inhibitormouse modelnovelprogenitorresponseself renewing cellself-renewalstem
项目摘要
DESCRIPTION (provided by applicant): The goals of this project are to define the mechanisms by which type I IFNs alter the fates of immature hematopoietic stem cells (HSCs) and progenitor cells, and to identify the effect and underlying mechanisms of type I IFNs on the health and potential of normal and leukemic HSCs. These studies will be carried out using HSCs and progenitor cells isolated from wild-type mice and from the SCLtTAxBCR/ABL double transgenic mouse model of human chronic myelogenous leukemia (CML), and a comprehensive array of in vivo and in vitro experimental approaches. In the first aim, we will investigate how short-term (days) and long-term (weeks) exposure to type I IFNs affects the biology of HSCs and progenitor cells with respect to their quiescence, proliferation, potential, and susceptibility to apoptosis. We will also examine whether chronic (months) exposure to type I IFNs damages HSC self-renewal. Lastly, we will define the molecular mechanisms underlying these changes. In the second aim, we will assess how type I IFNs affect the biology of leukemic HSCs and progenitor cells compared to wild type cells. We will investigate how the deregulated properties of BCR/ABL-expressing leukemic HSCs (i.e., increased proliferation, decreased quiescence, increase survival) change their response to type I IFNs exposure and may sensitize them to combinatorial treatments with type I IFNs and the BCR/ABL tyrosine kinase inhibitor, Imatinib. Taken together, these approaches should uncover how inflammatory signals such as type I IFNs impact on the regulatory networks that normally control HSC and progenitor cell homeostasis, and how the deregulated properties of leukemic HSCs may alter their sensitivity to the effects of inflammatory signals and therapeutic interventions.
PUBLIC HEALTH RELEVANCE: This project seeks to understand how type I interferons (IFNs), a large family of inflammatory proteins, affects the biology of hematopoietic stem cells (HSCs), a small population of bone marrow cells that generate all blood cells. Improper regulation of HSC activity can lead to a number of severe blood diseases. These include chronic myelogenous leukemia (CML), which has long been treated with type I IFNs despite the lack of knowledge regarding their mechanism of action. Recent clinical work suggests that type I IFNs may enhance the curative effect of other CML treatments, such as the tyrosine kinase inhibitor Imatinib. By uncovering how type I IFNs affect the biology of normal and leukemic HSCs, and the molecular mechanisms underlying these effects, the proposed work could be of significant value to public health by providing the basis for the design of more effective co-treatments for CML and other blood diseases that will harness the beneficial effect of type I IFNs.
描述(申请人提供):本项目的目标是确定I型IFN改变未成熟造血干细胞(HSCs)和祖细胞命运的机制,并确定I型IFN对正常和白血病HSCs的健康和潜能的影响和潜在机制。这些研究将使用从野生型小鼠和人慢性粒细胞白血病(CML)SCLtTAxBCR/ABL双转基因小鼠模型分离的HSCs和祖细胞,以及一系列全面的体内和体外实验方法进行。在第一个目标中,我们将研究短期(几天)和长期(几周)暴露在I型IFN下如何影响HSCs和祖细胞的生物学特性,包括它们的静止、增殖、潜能和对凋亡的敏感性。我们还将研究长期(几个月)暴露于I型IFN是否会损害HSC的自我更新。最后,我们将定义这些变化背后的分子机制。在第二个目标中,我们将评估与野生型细胞相比,I型IFN如何影响白血病HSCs和祖细胞的生物学。我们将研究表达bcr/abl的白血病HSCs的非调控特性(即增加增殖、减少静止、提高存活率)如何改变它们对I型IFN暴露的反应,并可能使它们对I型IFN和bcr/abl酪氨酸激酶抑制剂Imatinib的联合治疗敏感。综上所述,这些方法应该揭示炎症信号,如I型IFN如何影响通常控制HSC和祖细胞稳态的调节网络,以及白血病HSC的去调节特性如何改变其对炎症信号和治疗干预的影响的敏感性。
公共卫生相关性:该项目试图了解I型干扰素(IFN)是一大类炎性蛋白,如何影响造血干细胞(HSCs)的生物学,造血干细胞是一小部分产生所有血细胞的骨髓细胞。HSC活性调节不当会导致许多严重的血液疾病。其中包括慢性粒细胞白血病(CML),尽管对其作用机制缺乏了解,但长期以来一直使用I型IFN进行治疗。最近的临床研究表明,I型IFN可能会增强其他CML治疗的疗效,如酪氨酸激酶抑制剂伊马替尼。通过揭示I型IFN如何影响正常和白血病HSCs的生物学,以及这些作用背后的分子机制,拟议的工作可能对公众健康具有重要价值,为设计更有效的CML和其他血液疾病的联合治疗提供基础,从而利用I型IFN的有益效果。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric M Pietras其他文献
Eric M Pietras的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric M Pietras', 18)}}的其他基金
Aberrant glycolysis as a driver of mutant HSPC expansion in clonal hematopoiesis
异常糖酵解是克隆造血中突变型 HSPC 扩增的驱动因素
- 批准号:
10729107 - 财政年份:2023
- 资助金额:
$ 5.13万 - 项目类别:
Metabolic targeting of heterogenous myelodysplastic syndrome stem cells
异源性骨髓增生异常综合征干细胞的代谢靶向
- 批准号:
10788983 - 财政年份:2023
- 资助金额:
$ 5.13万 - 项目类别:
Impact of IL-1 signaling on hematopoietic stem cell function and emergence of clonal hematopoiesis.
IL-1 信号传导对造血干细胞功能和克隆造血出现的影响。
- 批准号:
10391755 - 财政年份:2019
- 资助金额:
$ 5.13万 - 项目类别:
Impact of IL-1 signaling on hematopoietic stem cell function and emergence of clonal hematopoiesis.
IL-1 信号传导对造血干细胞功能和克隆造血出现的影响。
- 批准号:
10507242 - 财政年份:2019
- 资助金额:
$ 5.13万 - 项目类别:
Impact of IL-1 signaling on hematopoietic stem cell function and emergence of clonal hematopoiesis.
IL-1 信号传导对造血干细胞功能和克隆造血出现的影响。
- 批准号:
10343816 - 财政年份:2019
- 资助金额:
$ 5.13万 - 项目类别:
Impact of IL-1 signaling on hematopoietic stem cell function and emergence of clonal hematopoiesis.
IL-1 信号传导对造血干细胞功能和克隆造血出现的影响。
- 批准号:
10579836 - 财政年份:2019
- 资助金额:
$ 5.13万 - 项目类别:
Pro-inflammatory cytokines in hematopoietic stem cell function
造血干细胞功能中的促炎细胞因子
- 批准号:
8768233 - 财政年份:2014
- 资助金额:
$ 5.13万 - 项目类别:
Pro-inflammatory cytokines in hematopoietic stem cell function
造血干细胞功能中的促炎细胞因子
- 批准号:
9057523 - 财政年份:2014
- 资助金额:
$ 5.13万 - 项目类别:
Pro-inflammatory cytokines in hematopoietic stem cell function
造血干细胞功能中的促炎细胞因子
- 批准号:
9186022 - 财政年份:2014
- 资助金额:
$ 5.13万 - 项目类别:
相似海外基金
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 5.13万 - 项目类别:
Training Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 5.13万 - 项目类别:
Standard Grant
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 5.13万 - 项目类别:
Standard Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 5.13万 - 项目类别:
Fellowship
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 5.13万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 5.13万 - 项目类别:
Research Grant
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 5.13万 - 项目类别:
Studentship
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 5.13万 - 项目类别:
Operating Grants
New Tendencies of French Film Theory: Representation, Body, Affect
法国电影理论新动向:再现、身体、情感
- 批准号:
23K00129 - 财政年份:2023
- 资助金额:
$ 5.13万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
The Protruding Void: Mystical Affect in Samuel Beckett's Prose
突出的虚空:塞缪尔·贝克特散文中的神秘影响
- 批准号:
2883985 - 财政年份:2023
- 资助金额:
$ 5.13万 - 项目类别:
Studentship